{
    "url_original": "https://www.wsj.com/articles/unilever-makes-approach-for-glaxos-consumer-healthcare-business-11642263875?mod=business_lead_pos4",
    "url": "unilever-makes-approach-for-glaxos-consumer-healthcare-business-11642263875",
    "title": "Unilever Makes Approach for Glaxo’s Consumer-Healthcare Business",
    "sub_head": "Company says toothpaste-to-painkiller unit would be strong strategic fit",
    "category_1": "Business",
    "image_1_url": "https://images.wsj.net/im-468761?width=860&height=573",
    "image_1": "im-468761.jpg",
    "time": "2022-01-15 11:58:00",
    "body": "LONDON— Unilever  PLC said it had approached  GlaxoSmithKline  PLC and  Pfizer Inc.  about an acquisition of their consumer-healthcare joint venture, a potential $68 billion deal that would reshape the consumer-products giant’s portfolio at a time when it is under pressure to accelerate growth.<br />Unilever said in a statement Saturday that the business, known as GSK Consumer Healthcare, was “a leader in the attractive consumer health space” and would be a “strong strategic fit,” though cautioned there was no certainty that any agreement would be reached."
}